Current trials

The Gynaecological Oncology Unit continues to be involved in a number of Australian and international research projects and clinical trials.  The unit has recently begun recruiting patients to take part in new clinical trials.

Your GP or oncologist can make referrals to:
Department of Gynaecological Oncology
Tel:  03 8458 8460
Fax: 03 8458 4878
Email: oncology@mercy.com.au

See below for further information and eligibility criteria:

Study Number
Tumour Type
Experimental Agent
Administration
Phase
Recruitment Status
Eligibility Criteria
Paragon
Ovarian cancer, Uterine 
or Endometrial cancers 
Aromatase inhibitor
Oral daily
Phase 2
Recruiting
See below
INCB
Ovarian cancer, Fallopian tube
or primary peritoneal cancers
IDO inhibitor versus Tamoxifen
Oral twice daily
Phase 2
Recruiting
See below
Icon8 
Ovarian cancer, Fallopian tube
or primary Peritoneal cancers
Dose - fractioned 
Carboplatin Paclitaxel 
versus standard 3-weekly 
Carboplatin Placlitaxel
Intravenous infusion
 3-weekly or weekly
Phase 3
Recruiting
See below
Solo 1
Ovarian cancer, Fallopian tube, 
primary Peritoneal or 
Endometrioid cancer
 (with BRCA mutation)
Olaparib (PARP inhibitor)
Oral twice daily

Phase 3

Recruiting

See below

Solo2
Ovarian cancer, Fallopian tube,
 primary peritoneal or 
Endometrioid cancer
 (with BRCA mutation)
Olaparib (PARP inhibitor)

Oral twice daily

Phase 3

Recruiting

See below

 

print text size increase